Stay updated on Nivolumab vs Chemo in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Chemo in Stage IV NSCLC Clinical Trial page.

Latest updates to the Nivolumab vs Chemo in Stage IV NSCLC Clinical Trial page
- CheckyesterdayChange DetectedExpanded the Locations section with numerous new study sites across the United States, Argentina, Australia, Canada, and Europe; revision updated to v3.3.3.SummaryDifference2%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check30 days agoChange DetectedPublications section disclaimer updated to indicate that publications are automatically filled from PubMed, and the revision/version label changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedThe government funding status banner on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedThe updates are limited to minor formatting and layout adjustments on the Study Details page; no core study content, eligibility criteria, or outcome data were added or removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check80 days agoChange DetectedSummary of changes: updated operating-status notice and a version bump to v3.2.0, replacing the previous v3.1.0.SummaryDifference2%

- Check87 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to Nivolumab vs Chemo in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Chemo in Stage IV NSCLC Clinical Trial page.